Literature DB >> 4303800

Thalidomide neuropathy: a clinical electrophysiological, and histological follow-up study.

P M Fullerton, D J O'Sullivan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4303800      PMCID： PMC496421          DOI： 10.1136/jnnp.31.6.543

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  22 in total

1.  TERATOGENIC ACTIVITY OF THALIDOMIDE AND RELATED COMPOUNDS.

Authors:  S FABRO; H SCHUMACHER; R L SMITH; R T WILLIAMS
Journal:  Life Sci (1962)       Date:  1964-09

2.  THE CONDUCTION VELOCITY OF REGENERATED PERIPHERAL NERVE FIBRES.

Authors:  B G CRAGG; P K THOMAS
Journal:  J Physiol       Date:  1964-05       Impact factor: 5.182

3.  PERIPHERAL NERVE CHANGES IN ORTHO-CRESYL PHOSPHATE POISONING IN THE CAT.

Authors:  J B CAVANAGH
Journal:  J Pathol Bacteriol       Date:  1964-04

4.  THALIDOMIDE: EFFECTS ON ENZYMES OF GLUTAMIC ACID METABOLISM IN MICE.

Authors:  E HIRSCHBERG; M OSNOS; S BRYANT; J E ULTMANN
Journal:  Science       Date:  1964-03-20       Impact factor: 47.728

5.  Neuropathy after intake of thalidomide (distaval).

Authors:  P M FULLERTON; M KREMER
Journal:  Br Med J       Date:  1961-09-30

6.  [Does thalidomide (contergan) cause injurious effects?].

Authors:  H J RAFFAUF
Journal:  Dtsch Med Wochenschr       Date:  1961-05-12       Impact factor: 0.628

7.  The relative excitability and conduction velocity of sensory and motor nerve fibres in man.

Authors:  G D DAWSON
Journal:  J Physiol       Date:  1956-02-28       Impact factor: 5.182

8.  Peripheral neuropathy in rats produced by acrylamide.

Authors:  P M Fullerton; J M Barnes
Journal:  Br J Ind Med       Date:  1966-07

9.  Fibre size and content of the anterior tibial nerve of the foot.

Authors:  M Swallow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1966-06       Impact factor: 10.154

10.  [Experimental animal studies on the question of thalidomide and nerve damage].

Authors:  M Staemmler; F Lagler
Journal:  Arzneimittelforschung       Date:  1965-05
View more
  29 in total

1.  Use of thalidomide in leprosy.

Authors:  M F Waters
Journal:  BMJ       Date:  1991-08-24

2.  Use of thalidomide in leprosy.

Authors:  C L Crawford
Journal:  BMJ       Date:  1991-06-29

Review 3.  HIV-associated neuropathic pain: epidemiology, pathophysiology and management.

Authors:  Susama Verma; Lydia Estanislao; David Simpson
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

4.  [Unmyelinated nerve fibers in senile nerves and in late thalidomide neuropathy: a quantitative electron microscopic study (author's transl)].

Authors:  J M Schröder; E Gibbels
Journal:  Acta Neuropathol       Date:  1977-08-31       Impact factor: 17.088

5.  Acrylamide neuropathy in rats. An electron microscopic study of degeneration and regeneration.

Authors:  K Suzuki; L D Pfaff
Journal:  Acta Neuropathol       Date:  1973-05-16       Impact factor: 17.088

6.  Transient dysaesthesiae and persistent leucocytosis after clioquinol therapy.

Authors:  S I Terry
Journal:  Br Med J       Date:  1971-09-25

7.  [What is the relevance of various previous lesions of the peripheral nervous system to a thalidomide polyneuropathy?].

Authors:  G P Liebaldt; F Broser
Journal:  Z Neurol       Date:  1971

8.  Vincristine neuropathy: an electrophysiological and histological study.

Authors:  J G McLeod; R Penny
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-08       Impact factor: 10.154

9.  Prevention of repeated episodes of type 2 reaction of leprosy with the use of thalidomide 100 mg/day.

Authors:  Maria Stella de Mello Ayres Putinatti; Joel Carlos Lastória; Carlos Roberto Padovani
Journal:  An Bras Dermatol       Date:  2014 Mar-Apr       Impact factor: 1.896

Review 10.  Peripheral neuropathy and cancer.

Authors:  Arthur D Forman
Journal:  Curr Oncol Rep       Date:  2004-01       Impact factor: 5.075
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.